Effect of prior malignancy on survival after cardiac surgery

Annals of Thoracic Surgery

Volumn 77, Issue 5, 2004, Pages 1593-1597

  Mistiaen, Wilhelm P ^a   Van Cauwelaert, Philip ^b   Muylaert, Philip ^b   Wuyts, Floris ^b   Harrisson, Fernand ^b   Bortier, Hilde ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NONE

Author keywords

18

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE; HEART SURGERY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARDIAC SURGICAL PROCEDURES; CAUSE OF DEATH; COLONIC NEOPLASMS; COMORBIDITY; CORONARY DISEASE; FEMALE; HEART VALVE DISEASES; HODGKIN DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS; PROGNOSIS; PROSTATIC NEOPLASMS; RECTAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 1942500936     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.08.049     Document Type: Article

References (19)

1. Kuper H., Bofetta P., Adami H.O. Tobacco use and cancer causation association by tumor type. J Intern Med. 252:2002;204-206.
2. Fagerstrom K. The epidemiology of smoking health consequences and benefits of cessation. Drugs. 62:(Suppl 2):2002;1-19.
3. Thomas L.A. Sending unhealthy environments up in smoke. Mich Health Hosp. 38:2002;20-21.
4. Danton M.H.D., Anikin V.A., McManus K.G., McGuigan J.A., Campalani G. Simultaneous cardiac surgery with pulmonary resection presentation of series and review of literature. Eur J Cardiothorac Surg. 13:1998;667-672.
5. Al-Attar N., Salvi S., Sebbag U., Nataf P. Combined left pneumonectomy and off-pump coronary artery bypass through left thoracotomy. Eur J Cardiothorac Surg. 19:2001;226-228.
6. Hensens A.G., Zeebregts C.J., Liem T.H., Gehlmann H., Lacquet L.H. Concomitant coronary artery revascularisation and right pneumonectomy without cardiopulmonary bypass. J Cardiovasc Surg. 40:1999;161-163.
7. Rubens F.D., O'Brien E., Shamji F., O'Neil J., Odell P.F. Sternothoractomy for combined coronary artery bypass grafting and left upper lobectomy in a patient with low-lying tracheostoma. Can J Surg. 42:1999;143-144.
8. Jones J.M., Melua A.A., Anikin V., Campalini G. Simultaneous transhiatal esophagectomy and coronary artery bypass grafting without cardiopulmonary bypass. Dis Esophagus. 12:1999;312-313.
9. Yokoyama T., Derrick M.J., Lee A.W. Cardiac operation with associated pulmonary resection. J Thorac Cardiovasc Surg. 105:1993;912-917.
10. Mistiaen W.P., Van Cauwelaert P., Muylaert P., et al. Determinants of survival after aortic valve replacement as treatment for symptomatic aortic valve disease in the elderly. J Heart Valve Dis. 10:2001;354-360.
11. Markewitz A., Lante W., Franke A., Marohl K., Kuhlmann W.D., Weinhold C. Alterations of cell-mediated immunity following cardiac operations clinical implications and open questions. Shock. 16:(Suppl 1):2001;10-15.
12. Sablotski A., Welters I., Lehmann N., et al. Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-beta in patients undergoing coronary artery bypass grafing. Eur J Cardiothorac Surg. 11:1997;763-768.
13. Markewitz A., Faist E., Lang S., Hultner L., Weinhold C., Reichart B. An imbalance in T-helper cells subsets alters immune response after cardiac surgery. Eur J Cardiothorac Surg. 10:1996;61-67.
14. Payen D., Faivre V., Lukaszewicz A.C., Losser M.R. Assessment of immunological status in the critically ill. Minerva Anestesiol. 66:2000;757-763.
15. O'Byrne K.J., Dalgleish A.G., Browning M.J., Steward W.P., Harris A.L. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer. 36:2000;151-169.
16. Nanni P., Nicoletti G., De Giovanni C., et al. Combined allogeneic tumour cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/leu trangene mice. J Exp Med. 194:2001;1195-1205.
17. Lamm D.L., Riggs D.R. The potential application of Allium Sativum for the treatment of bladder cancer. Urol Clin North Am. 27:2000;157-162.
18. Mise-Omata S., Sugiura T., Higashi K., Yamashita U. Reduces T cell response in carcinogen-sensitive Donryu rats compared with carcinogen-resistant DHR rats. Jpn J Cancer Res. 90:1999;1277-1284.
19. Enwonwu C.O., Meeks V.I. Bionutrition and oral cancer in humans. Crit Rev Oral Biol Med. 6:1995;5-17.